title: Multifocal necrotizing leukoencephalopathy: An unusual complication of acute leukemia.
authors.affiliation: Department of Interdisciplinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, Neuro-Oncology Program, Tampa, FL 33612, USA.
authors.forename: John
authors.initials: J
authors.lastname: Robb
authors.forename: Lisa
authors.initials: L
authors.lastname: Chalmers
authors.forename: Amyn
authors.initials: A
authors.lastname: Rojiani
authors.forename: Marc
authors.initials: M
authors.lastname: Chamberlain
mesh_terms: D000208:Acute Disease; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D001706:Biopsy; D003520:Cyclophosphamide / Q000009:adverse effects; D003561:Cytarabine / Q000009:adverse effects; D003907:Dexamethasone / Q000009:adverse effects; D004317:Doxorubicin / Q000009:adverse effects; D006801:Humans; D015459:Leukemia-Lymphoma, Adult T-Cell / Q000188:drug therapy*; D007968:Leukoencephalopathy, Progressive Multifocal / Q000139:chemically induced* / Q000473:pathology*; D008279:Magnetic Resonance Imaging; D008297:Male; D008727:Methotrexate / Q000009:adverse effects; D008875:Middle Aged; D009336:Necrosis; D014750:Vincristine / Q000009:adverse effects
chemical_list: D000964:Antimetabolites, Antineoplastic; D003561:Cytarabine; D014750:Vincristine; D003907:Dexamethasone; D004317:Doxorubicin; D003520:Cyclophosphamide; D008727:Methotrexate